Topics

Human medicines European public assessment report (EPAR): Ravicti,  glycerol phenylbutyrate, Urea Cycle Disorders, Inborn, Date of authorisation: 26/11/2015, Revision: 11, Status: Authorised

10:35 EDT 3 Oct 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Ravicti,  glycerol phenylbutyrate, Urea Cycle Disorders, Inborn, Date of authorisation: 26/11/2015, Revision: 11, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Ravicti,  glycerol phenylbutyrate, Urea Cycle Disorders, Inborn, Date of authorisation: 26/11/2015, Revision: 11, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Ravicti,  glycerol phenylbutyrate, Urea Cycle Disorders, Inborn, Date of authorisation: 26/11/2015, Revision: 11, Status: Authorised"

Quick Search